J. Tate Thigpen, MD | Authors

Articles

Treating Older Patients With Ovarian Cancer: Another Perspective

December 01, 2008

Dr. Piver presents a personal look at the issues he believes to be important in managing ovarian carcinoma in the elderly patient. He begins with an attempt to define elderly.

Commentary (Thigpen): Update on Radiation Therapy for Endometrial Cancer

June 01, 2002

Dr. Grigsby has done a masterful job of summarizing current information on the use of radiation in the management of patients with endometrial carcinoma. In the summary, he offers clear recommendations as to the appropriate management of various subsets of patients-recommendations that are based, at least to some extent, on the data reviewed. Such decision-making based on often incomplete information is necessary in the absence of appropriately designed randomized trials addressing the specific clinical situation. It is important, however, to understand clearly what we actually know and what we deduce from bits and pieces of data.

Book Review: Textbook of Uncommon Cancer, Second Edition

February 01, 2001

The second edition of the Textbook of Uncommon Cancer is a useful resource for practicing oncologists who encounter unusual presentations of common tumors or esoteric subtypes of more common cancers. The text is laid out according to

Is There a Role for Intraperitoneal Chemotherapy in the Management of Ovarian Cancer?

January 01, 2001

Phase I and II clinical trial data have demonstrated the safety, pharmacokinetic advantage, and potential for enhanced cytotoxicity associated with the intraperitoneal administration of antineoplastic agents in the

Commentary (Thigpen): The Management of Early Ovarian Cancer

February 01, 1995

Schilder and colleagues have provided a detailed and excellent review of the management of early ovarian carcinoma. Several areas of the review deserve comment and will be considered in the following order: staging and prognostic factors, conservative surgery, and adjuvant therapy.